Drug Discovery Platform Verseon Launches Blockchain-Based Securities Exchange

Cointelegraph

Published Sep 18, 2018 08:21AM ET

Updated Sep 18, 2018 08:41AM ET

Drug Discovery Platform Verseon Launches Blockchain-Based Securities Exchange

U.S. pharmaceutical company Verseon has become the latest medical organization to experiment in blockchain technology, it confirmed in a press release Tuesday, September 18.

Verseon’s main product is its proprietary physics-based drug discovery platform. The company was established in 2002 and it now trades on the London Stock Exchange, boasting a market cap of £211 million ($277 million).

Continue Reading on Coin Telegraph